Trial Profile
A Study to Evaluate the Efficacy and Safety of Telaprevir-based Triple Therapy in Treatment-naive and Pretreated Patients with Chronic Hepatitis C Virus (HCV) Genotype 1 Infection
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 15 Dec 2015 New trial record